Recent market declines have left these solid players trading at rock-bottom prices.

Target thrived in the initial stages of the pandemic; it is now adjusting to changing consumer habits that are working against the retailer.

A top retailer and a pharmaceutical giant both now boast dividends that yield more than 3%.

Short-term challenges have led to an overreaction and presented a great buying opportunity.

Part of the uncertainty in the market at present is related to how earnings estimates should evolve in an aggressive Fed tightening cycle. The market has a sense of what should happen to earnings esti...

Part of the uncertainty in the market at present is related to how earnings estimates should evolve in an aggressive Fed tightening cycle. The market has a sense of what should happen to earnings esti...

Investors can still profit in this sector despite the toll inflation is taking.

It's time to prepare your portfolio for long-term growth.

When Target (NYSE: TGT) warned the market its Q2 earnings could fall short it was dire news for the market. The idea that inventories were bloating, sales were slowing, and a new era of discounting is...

Target's share price has plummeted since the company reported disappointing Q1 earnings. Target's recent dividend hike brings the stock's yield to one of its highest points ever.